The EGLN1 gene plays a critical role in how the body responds to oxygen levels, and mutations in this gene can lead to Erythrocytosis Familial Type 3, a rare condition characterized by an abnormal increase in the number of red blood cells. This can lead to various symptoms, including headaches, dizziness, and an increased risk of blood clots. Early diagnosis and management are crucial to mitigate these risks.
DNA Labs UAE offers a genetic test specifically designed to detect mutations in the EGLN1 gene associated with Erythrocytosis Familial Type 3. This test is a valuable tool for individuals with a family history of the condition or those exhibiting symptoms, providing them with crucial information about their genetic health. The cost of the test is 4400 AED, reflecting the specialized analysis and the comprehensive nature of the genetic insights it provides. Conducted in a state-of-the-art facility, the test results are delivered with accuracy and precision, offering a reliable basis for diagnosis and further medical consultation.
The EPAS1 Gene Erythrocytosis Familial Type 4 Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the EPAS1 gene, which are known to cause Familial Erythrocytosis Type 4. This condition is characterized by an abnormal increase in the number of red blood cells, leading to a thickening of the blood and potentially causing complications such as blood clots, strokes, and heart attacks. The test is crucial for individuals with a family history of erythrocytosis or those exhibiting symptoms related to high red blood cell counts, as early detection can facilitate appropriate management and treatment strategies.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves a detailed analysis of the EPAS1 gene to pinpoint specific mutations. The process is thorough and is carried out by experienced professionals using state-of-the-art technology to ensure accuracy and reliability of the results.
The cost of the EPAS1 Gene Erythrocytosis Familial Type 4 Genetic Test is set at 4400 AED. While the price may seem steep, it reflects the intricate technology and expertise required to accurately identify mutations in the EPAS1 gene. For those at risk, this test provides invaluable information that can aid in the prevention of serious health issues associated with Familial Erythrocytosis Type 4, making it a potentially life-saving investment.
The F10 Gene Factor X Deficiency Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the F10 gene, which are responsible for Factor X deficiency. Factor X deficiency is a rare genetic disorder that affects the blood's ability to clot properly, leading to an increased risk of bleeding or excessive clotting. This condition can vary in severity and may manifest as mild to severe symptoms, depending on the level of Factor X activity in the blood.
The test is crucial for individuals who have a family history of bleeding disorders or have experienced symptoms related to abnormal blood clotting. Early detection through this genetic test can aid in the proper management and treatment of the condition, potentially preventing severe complications.
The cost of the F10 Gene Factor X Deficiency Genetic Test at DNA Labs UAE is set at 4400 AED. This price reflects the comprehensive nature of the test, including the sophisticated technology and expertise required to accurately identify mutations in the F10 gene. Undergoing this test at DNA Labs UAE ensures that patients receive reliable results, thanks to the laboratory's commitment to maintaining high standards of accuracy and confidentiality in genetic testing.
The G6PD gene test, aimed at determining susceptibility to Favism, is a crucial genetic assessment available at DNA Labs UAE. Favism is a condition triggered by a deficiency in the enzyme glucose-6-phosphate dehydrogenase (G6PD), which is vital for red blood cell function. This deficiency can lead to hemolytic anemia, especially after consuming fava beans or certain drugs. The test specifically identifies mutations in the G6PD gene, helping to diagnose the deficiency and enabling individuals to take preventative measures against potential triggers.
Conducted at the state-of-the-art facilities of DNA Labs UAE, the test is priced at 4400 AED. It is a valuable tool for those with a family history of G6PD deficiency or individuals of ethnicities with higher prevalence rates, offering them an opportunity to understand their genetic risk and manage their health proactively.
The CYBA gene granulomatous disease, also known as Chronic Granulomatous Disease (CGD) of the cytochrome b-negative type, is a rare autosomal recessive disorder. This condition is characterized by a deficiency in one of the components of the NADPH oxidase complex, specifically due to mutations in the CYBA gene. This enzyme complex plays a crucial role in the immune system's ability to produce reactive oxygen species, which are vital for killing certain bacteria and fungi. As a result, individuals with this condition are highly susceptible to recurrent and severe infections.
The genetic test for this specific form of CGD involves analyzing the CYBA gene to identify mutations that cause the disease. This test is crucial for early diagnosis, which can significantly impact the management and prognosis of the disease. Early and accurate diagnosis allows for appropriate treatment strategies to be implemented, which may include prophylactic antibiotics, antifungal medications, and in some cases, bone marrow transplantation.
In the United Arab Emirates, DNA Labs UAE offers this specialized genetic test. The cost of the test is 4400 AED. DNA Labs UAE is equipped with state-of-the-art technology and staffed by experts in the field of genetic testing, ensuring accurate and reliable results. By providing this test, DNA Labs UAE plays a vital role in the early detection and management of CYBA gene granulomatous disease, ultimately improving the quality of life for affected individuals.
The NCF2 gene is implicated in a rare genetic disorder known as Chronic Granulomatous Disease (CGD), specifically the autosomal recessive cytochrome b-positive type 2. CGD is characterized by the body's inability to effectively combat infections, leading to the formation of granulomas, which are clusters of immune cells formed at sites of infection or inflammation. The NCF2 gene plays a critical role in the immune system's functioning, particularly in the production of reactive oxygen species by phagocytes that are essential for killing certain bacteria and fungi.
Individuals with mutations in the NCF2 gene have a reduced capacity to produce these reactive oxygen species, making them more susceptible to infections. Genetic testing for mutations in the NCF2 gene can confirm a diagnosis of CGD and help in managing and treating the condition more effectively.
In the United Arab Emirates, DNA Labs UAE offers a genetic test for identifying mutations in the NCF2 gene. The test is crucial for families with a history of CGD, as it can help in early diagnosis and intervention for affected individuals. The cost of the test is 4400 AED. Early diagnosis through genetic testing can significantly improve the quality of life for individuals with CGD by enabling tailored treatments and preventive measures against infections.
The NCF4 gene, associated with Granulomatous Disease Chronic Autosomal Recessive Cytochrome b-Positive Type 3 (GD CAR Cytochrome b-Positive Type 3), is crucial for the proper function of the immune system. Mutations in the NCF4 gene can lead to a form of primary immunodeficiency that affects the body's ability to form the reactive oxygen species necessary for killing bacteria and fungi, leading to increased susceptibility to infections.
This genetic condition is inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected by the disease. Symptoms can vary but often include recurrent infections, granulomas (clusters of immune cells forming lumps), and other immune system-related issues.
Testing for mutations in the NCF4 gene is crucial for the diagnosis of GD CAR Cytochrome b-Positive Type 3. DNA Labs UAE offers a genetic test specifically designed to identify mutations in the NCF4 gene, aiding in the diagnosis and management of this condition. The cost of the test is 4400 AED. This test is a valuable tool for individuals with a family history of the disease or those presenting symptoms consistent with the condition, enabling early intervention and management strategies to be put in place.
The CYBB gene granulomatous disease chronic X-linked genetic test is a specialized diagnostic tool designed to identify mutations in the CYBB gene, which are associated with Chronic Granulomatous Disease (CGD). CGD is a rare genetic disorder that affects the immune system, making it difficult for the body to fight infections. This condition is X-linked, meaning it predominantly affects males, although females can be carriers and may exhibit symptoms in some cases.
The test is carried out at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. By analyzing the DNA sample, usually obtained from blood, this test can confirm the presence of specific genetic alterations in the CYBB gene that lead to CGD. Early diagnosis through this test can be crucial for the management and treatment of the condition, allowing for tailored therapies that can significantly improve the quality of life for affected individuals.
The cost of the CYBB gene granulomatous disease chronic X-linked genetic test at DNA Labs UAE is 4400 AED. This price reflects the sophisticated nature of the testing process and the invaluable insights it provides for the management of Chronic Granulomatous Disease. For families and individuals facing the possibility of CGD, this test represents a critical step towards understanding and managing the condition effectively.
The G6PD Gene Hemolytic Anemia Due to G6PD Deficiency Genetic Test is a critical diagnostic tool available at DNA Labs UAE, aimed at identifying individuals with Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency. G6PD is an essential enzyme in the body that helps protect red blood cells from damage and premature destruction. A deficiency in G6PD can lead to hemolytic anemia, a condition where red blood cells are destroyed faster than they can be made, causing symptoms like fatigue, jaundice, and in severe cases, kidney failure or death.
This genetic test specifically looks for mutations in the G6PD gene that are responsible for the enzyme deficiency. By examining a small sample of blood or saliva, the test can accurately identify variations in the G6PD gene that may lead to the condition. This information is vital for early diagnosis and management of the disorder, which can significantly improve the quality of life for affected individuals.
The cost of the G6PD Gene Hemolytic Anemia Due to G6PD Deficiency Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis required to detect the genetic mutations associated with G6PD deficiency. Given the potential health implications of the disorder, this test is an invaluable resource for individuals with a family history of G6PD deficiency or those exhibiting symptoms of hemolytic anemia. Early detection through this genetic test allows for the implementation of preventive measures and appropriate treatment plans, reducing the risk of severe complications associated with the condition.
The TPI1 gene is responsible for encoding the enzyme triosephosphate isomerase, which plays a critical role in glycolysis, the metabolic pathway that converts glucose into energy. Mutations in the TPI1 gene can lead to a rare but severe condition known as triosephosphate isomerase deficiency. This autosomal recessive disorder is characterized by a wide range of symptoms, including hemolytic anemia, neuromuscular impairments, and, in severe cases, early childhood death.
To diagnose this condition, genetic testing is conducted to identify mutations in the TPI1 gene. In the UAE, DNA Labs offers a specific test for this purpose. The test involves analyzing the patient's DNA to detect any abnormalities in the TPI1 gene that could indicate the presence of triosephosphate isomerase deficiency. This genetic test is crucial for early diagnosis and management of the condition, allowing for appropriate treatment plans to be developed.
The cost of the TPI1 gene hemolytic anemia due to triosephosphate isomerase deficiency genetic test at DNA Labs UAE is 4400 AED. Given the complexity and the specialized nature of this test, it represents a significant investment in the health and well-being of individuals at risk of or suspected to have this rare genetic disorder. Early detection through such genetic testing can significantly impact the management of the disease and the quality of life for affected individuals and their families.
